Miranda Kramer

Miranda Kramer is a researcher at the University of Groningen's Faculty of Medical Sciences, specifically affiliated with the University Medical Center Groningen (UMCG). She holds active positions in two key research programs: Personalized Cancer Treatment (PCT) and Innovative Clinical Studies and Long-term Treatment Consequences in Cancer (InClinS).

Her research expertise spans neuro-oncology with particular focus on:

• Low-grade Glioma diagnosis and treatment monitoring
• Advanced Magnetic Resonance Imaging techniques for brain tumors
• Radiation Therapy applications, especially Proton Therapy
• Brain Metastasis management following immunotherapy
• Neurocognitive effects of cancer treatments

Dr. Kramer's recent publications demonstrate a strong trajectory in developing and validating imaging biomarkers for treatment response assessment in neuro-oncology. Her work bridges technical advancements in medical imaging with clinical applications, particularly in the areas of diffusion-weighted imaging, deep learning applications for segmentation, and proton therapy dosimetry. She contributes significantly to understanding the long-term consequences of cancer treatments on neurological function.

Scientific Recognition

• Recipient of the 2023 academic prize for research on "Proton therapy in patients with lower grade glioma: the effects on neurocognitive functions and neuroradiological indices"

Dr. Kramer is actively involved in the ProTRAIT-Neuro-oncology clinical trials research infrastructure project. Her collaborative network includes multiple Dutch institutions focused on advancing neuro-oncology care through innovative imaging and radiation therapy approaches. She has developed a distinctive research fingerprint centered around brain tumor imaging, radiation oncology, and treatment response assessment.